Editorial Commentary
Olverembatinib for the treatment of chronic myeloid leukemia in chronic phase
Annals of Blood
2024;
9:
27
(30 September 2024)
Brief Report
Limited potential of sheep as a large animal to model transfusion-related acute lung injury mediated by antibodies against human neutrophil antigen 3a
Annals of Blood
2024;
9:
26
(30 September 2024)
Review Article
Advancing through challenges: current strategies in sickle cell disease management
Annals of Blood
2024;
9:
25
(30 September 2024)
Original Article
Predictive Model of variable laboratory findings calculation and monitoring during plasmapheresis procedures
Annals of Blood
2024;
9:
24
(30 September 2024)
Original Article
Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis
Annals of Blood
2024;
9:
23
(30 September 2024)
Editorial
Preface to the special series “Blood Transfusion Practice in ECMO Patients”
Annals of Blood
2024;
9:
22
(30 September 2024)
Editorial
RH alleles: historical milestones, molecular advances, and clinical application
Annals of Blood
2024;
9:
21
(30 September 2024)